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Introduction
Granuloeytopenia is a disea.se of medicine's own
making.

It has developed 1n the wake of a rapidly ex-

panding medical science - chemotherapy.

Unlike many

other- untoward effects of chemotherapy, this disease
is frequently fatal.

Lay and professional rebuke of a

physician is ' bitter when death is the direct result or
his therapy.

These cases weigh heavily when balanced

against· those which were benefited by the therapy.

For

this reason granulocytopenia deserv·es attention out or
proportion to its incidence.

It behooves the physician

to have an accurate conception of this disease especially regarding ettology, diagnosis and treatment.•
It 1s the purpose of this paper to show how granulocytonen1a has been established as a clinical entity,
to discuss its eti"ology and to give a complete account
of- the therapeutic methods advanced.

Many- therapeutic

measures have been advanced - most have proved to be
of no value.

A few seem to be somewhat effective but

the specific the rapy is yet to be found.

GRANULOCYTOPENIA
Nomenclature
It is qu1 te genera.1 ly accepted among· authori t ·ies
that the first · unm1·s takable description of granulocyj,openia was that of Schultz 1n 1922 (113).

Schultz intro-

duced the disease as "agranulocytosis 1' in an attempt to
stress the importance of the blood picture.

A short

time later, Friedemann (42) impressed by the freouency
of painful oral and pharyngeal lesions., suggested the
designation "agranulocytic ang,na 11·•

Expressions similar

1n connotation are "sepsis agranulocytlca," "angina
necroticans," "mucos1t1s" and "mucos1t1a necrot1cans
agranulocyt1ca; terminology used occasionally in early
German and American writings. (Dameshek - 23).

Though

etymologically incorrect the two former· terms became
very ·popular and are so f1rmly ·entrench-ed in medical

literature that newer and more exact nomenclature yet
has comnarative little usage.
This disease is most appronriately named "granulocytopenia; expressing a d1minut1 ve of granulocyt·e s in the
blood stream which marks the most· outstanding· feature o-f
the d 1sease and is sugge s t 1ve somewha:t · of th-e underlying
pathology..

Very good synonyms br, ve been su ~gested, of

these "malignant neutropen1a," ttmal1gnant granulocytonen1a,"
ttpern1eious leucopen1a" have been used with sufficient
frequency to deserve mention. (Dameshek - 23).

ttra10-

pathic neutropenia 11 is a. term sometimes used in granulopenia states in which the etiology remains obscure_
(Baldredge - 5).
Many closed allied conditions have been described
which have similar and often confusing nomenclature.

Rosenthal (105) describes a "malignant leucopenia" in
which the whole blood picture is depressed yet there is

a relative granulocytos1s.

Connor (16) discusses a "hypo-

granulocytosis" in which the depression of the granulocytes is a mild one. ·We1~s (133) described a related
condition in which the leucoeytes were increased in number yet showed lack of motility and ability to phagocytize.

He called this condition "dysplastic granulocytica".

Pewney (92) described a mild form, "agranulocytosis forme

fruste," in which there waS' a thrombocytopen1a and bleeding was an outstand1ng symptom~ (Miloslavich - 7).
Some authorities have been reluctant to accept .

sueM

fine differentiation and in some cases the identical
etiological agents apr.arently cause a different response.
These men prefer to ·de,scri be the whole groun as "agranulocyt1c syndromes.~
Definition
The establishment· of granulocytopenia a-s a clinical
entity (Miloslav1ch - 85) has been a d1ff1-cult problem.
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Some have refused to accept it as such, ma1nta1n1ng
that extreme leucopenia and a relative granulocytopenia. are not in themselves sufficient criteria for
the definition of a clinical entity.

Their criticism

was well justified in the early history· of the disease
but with elucida.tion of the etiology and pathology its
existence is nc:bwell substantiated.

Kracke (74) ably

defends thia concept, writing:
"Agra.nulocytosis· is a distinct clinical entity with
a clear-cut pathological picture, a definite clinical
course with stgns· and symptoms and a blood picture that
is as characteristic as that seen in pernicious anemia."
Schultz desert bed ·granul·ocytopen1a as a disease of
sudden onset with chills, a high fever, extreme prostra•
tion, necrot1e· lesions in ·the mouth and throat,_ a slight
· jaundic·e·, and a blood picture · wt th depression or complete
absen-ee · of granulo·cytes~

There is a · -rapid loss of weight

and death within a· few days;

Little can be added to this

definition; indeed, in light of newer knowledge of the
disease there is a tendency to ·simplify ·it.

It may then

be desc·ribed ··as an- ·a·c ute SIJlld-rome··in" ·which ·there·· is a
marked· d·epres sion of' the granulo·c yte·s .·followed by an
0

unresisted bacterial invasion ·of the mttcous membranes.
Incidence
Granulocytopenia is a new d1s·e a:se.

Had 1 t existed

to any great· extent -orior to 1922 1t would undoubtedly
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have been described long before.

The disease runs a

dramatic course and has such a high mortality rate
that it most certainly wou ld have attracted considerable clinical at·tention.

Had the - clinical nicture

been confused 1 t is un lil{_ely that 1 t would have escaned
the pathologist.

Blood studies had been routine fifty

years prior to 1922 in most large hospitals.
Medical historians have been able to find renorts
of an occasional case t'rior to 1922.

Two were undeni-

able, true gra.nu1ocytonenia, one, a case renorted by
Brown in 1902 (12) and the other rer.orted by Tuerck in
1907 (27).

Other reports suggesting this syndrone were

those of Dwyer (33) in 1904 and Strueberg (122) in 1915.
It seems ~likely that a few other cases have occurred but
we r e not recognized, or, in all probab111ty, , were o-laesified as severe' sent1c condltione, sch as malignant
diphtheria.
Since 1922, in contrast, there have been many
renorts .

To illustrate, Jacl{son (63) in a careful survey

of the cases in l iterature between the yea.rs 1933-1937
found nearly five hundred cases.
Early renorts suggested- a. much hi gher incidence
of this disea se in women than in men.
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Of the first one

. bundred twenty-1rnven CBJ3-es reported e1gh·ty-eignr, per cent
were women.

(Rosenthal - 105).

Later Taussig (124) re-

ported that of three hundred thirty cases sixty-eight
per cent were women·.

In the most recent reports the in-

cidence seems to be eaually divided among the two sexes.
(Morgan - 86).

A possible explanation for this change

is a coincident change in· etiology..

In the first series

amino pyrine oredominated as a causative agent, whereas
more recent granulocytos1s is predominantly sulfonamide
induced.
Early reports gave the impression that the disease
was a disease of the middle-aged.

Taussig (124) 1n a

careful survey of three hundred thirty· cases (1931) recorded the following:

Age

Incidence

Under 20 years of a§e • . . . .
II
II
. . . .
20 - 40
II
. . .
40 - 60
"ti
"11
Over 60
.
.
. .
"

. . ..

9%
38%
40%

13%

This might suggest -that· people of the middle-aged
group· were more · susceptible to the · di·sease than the
children.

A more likely explanation 1s that this age

group used various coal-tar derivat·ives more frequently
than children. · Morgan (86) saw no rela.ttonsh1p to age
·1n bl-s · seri·e s.
According to Kracke and Roberts (103) predisposition to granulocytopenia is seen in individuals· manifest-
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tng a chronic leuconenia •• This state is most common
among middle-aged women.
Etiolo&
Infectious theories of Etiolo&
Early investigators (Lovett -78) (Mackeen -80)
regardedagranulocytosis as an infectious disease, postulating that the mucous membrane lesion was primary and
the leucocytic depress·1on secondary, resulting from an
overwhelming septicemia.

(Hart -54).

Cultures from the

lesion revealed only the common inhabitants of the
mouth·.

Blood cultures were carefully examined.

Reports

in which staphylococcus, streptococcus, Friedlander' s·
bacillus, the fusirorm bacillus, and Borrel1a v1ncent1
were foun~ often 1n pure culture, were published but

n-one of these occurs in a larg·e enough series of cases
to deserve comme·n t.

A large number of reports incrim-

inated Bactllus pyocyaneous.
Lovett (78) in 1924 cultured this organism from
an oral lesion, injected the bacillus into the peritoneal
cavity

or

guinea pigs and obtained a reduction in • the

total leueocyte count and· evidence of toxic degeneration
of those remaining.

It was her contention that this

organism produces a toxin which has a depressant effect
upon the leucocytes.

In an attempt to prove this hypo-

thesis she treated leucocytes in vitro with filtrates
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from the organism grown under anaerobic conditions.
There was no apparent effect upon the activity of the
cells.

Dasse (25) repeated the latter experiment and

was able to produce a leucocytic reduction and a pro•
found neutronh111c depre-ssion.

Stillman (21) believed

there was a relationship between Bacillus pyocyaneous
and granulocytic depression.

Kracke (26), however,. in

an attempt to decide the status of Bacillus pyocyaneous
cultured the organism from the blood of a patient who
died of granulocytopenia and· was unable to produce any
leucopenic reaction· when this organism was injected into
a guinae nig.

The present consensus is that the infec-

tion is nothing more than secondary.

(Jackson -66- 1935).

Overwhelming infection may cause a depression in
the peripheral leucocyte count.

This condition to which

the title "malignant leucopen1a 11 is frequently applied
is not to be confused with granulocytopenia.

In malig-

nant leucopenia the blood .shows a relative granulocytosis,
many of the granulocytes containing toxic granules.

The

bone marrow 1s ordinarily hyperplastic but may be necrotic if the ·infection has involved the marrow.
The bacterial invasion, while secondary, is responsible for much of the pathology and still must be
combatted even if the primary disorder 1s rectified.
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Toxic Theory ofEt1ol.Dgy
Many therapeutic measures ·have ·b een shown to play
a definite part in theetiology of granuloeytopenia.

It

1s essential that the effect of these drugs be known so
that their use may be ·a voided where poe·s ible or the
proper precautions used in cases in which the use of the
drug is imperative.
~reohenamine.

Kastlin (19) in 1927 reported

granulocytopenla and · death in two cases following arsenical ant1-syph111t1c therapy.

His report seemed to- draw

the attention ·o f ·other physicians t ·o this complication
and other reports were forthcoming.

Three years later

Rosenthal (125) reviewed forty cases· exhibiting profound
leucopenia. following· the use of the arsenicals·.

Most

of these cases - exhi bi t ·e d considerable depression of the
erythropoetic tissue as· well and would, therefore. be
best· classified a·s ••a-plastic ane!)!ia."

In a few of

these cases the · granulocytes were -d epressed out of proportion to the other formed elements of the blood sufficiently to be classified as granulocytopenia.

Gran-

ulocyt~pen1a due to a.rsenical therapy, however, seems
to be rare.

Out of nearly n·lne hundred thousand 1n-

Ject1ons made by the U~1ted States Navy in 1938 there
were only three such compl1c1.t1ons.
mild, the other f"aj,_al.

Two of these were

Only twenty cases were discovered
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by Jackson (63) in a critical survey of all literature

up to 1939.
There seems to be no difference in toxicity of the
various , arsenicals.,

There are cases implicating

neoarsphenamine and sulfarsphenam1ne as well as arsphenamine.
Aminopyrine.

In 1931 Krake (26) reported a case

of recurrent acute attacks - of ,granulooytopenla interspersed
with periods of chronic mild leucopen1a.

In the history

it was discovered that the patient had been using large
amounts of coal tar derivatives.

Attention was directed

to ,a possible drug etiology by the uresence of methemoglob1n.

It ls now believed that most of the early cases
were a result of the use of these coal-tar products.
Kracke points out that the geographical distribution of
the disease clo~ely colncides with the consumption of
these products, that many of the victims of the disease
have been those who have had · easy access to these· drugs
(physicians, nurses, hospital attendants, .et cetera,)
and that the introduction of aminopyr1ne and the first
reports · of · the disease occurred at about t 'he same time.
The specific coal-tar produet· which seemed to be the
most toxtc wa·s aminopyr1·n e.

Cases of granulocytol)'enia

following aminopyrtn_e_became more and more freouent ln
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Undeniable ev1dence of the importance ot

literature.

aminopyrine as an etiological factor was furnished by
Benjamin (9).

He reported a case · 1n which· he suspected

aminopyrine as the etiological agent.

This case r-epot1ded

to the discont i nuation of the drug and Ro·entgenotherapy.
During a ueriod of good health following remission he
administered ten grains of the drug.

There then followed

a dramatic dron in the granulocytic count.

Within forty-

eight hours a typical picture of granulocytosis was manifested.

Holton (55) reported the development of granulo-

cytopenia after a single dose of am i nopyrine in a man
having used the drug severa l years before.
Aminonyrine has probably been the moat common
cause of granulocytopen1a.

In Denmsrk where its nro-

duct1on 1a curtailed there are extremely few cases
reported.

Jackson (63) in 1939 renorted three hundred

ninety eases 1n which aminopyr1ne was definitely the
etiologp/factor.

Goodman and Gilman (/40) believe

that it 1s the only drug that produces the typical picture
of granulocytopenia.

It is true tha t this drug rarely

affects any blood elementsDinitrophenol.

D1nitrophenol has had a e1mllar

history to that of am1nopyr1ne.
much shorter.

It has fortunately been

Soon -.gfter · 1ts introduction tor the ·

treatment of · obes1 ty~- t.t became apparent tha t t t too could
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cause a leukocytic depress~on.

Dameshek (21) reported

two cases, Jackson (63) seven.

Other reports may be found

in Davidson (26).
Sulfonamides.

Of greater importance than either

aminopyrine or dtnitrophenol are the sulfonamide drugs
and their relationship to the production of this syndronte.
The use of the former drugs may be curtailed and their
problem ls answeredbut sulfonamides are now almost indispens_a ble in medical practice.
It is interesting to know that Fitz-Hugh (37) in

1937, before any sulfonamide-induced granuloeytopenia had
been reported, predicted that the sulfonamides might well
be implic a ted 1n its production -in view of their chemical
nature.

The first actual reports were those of Kracke

(75) 1n 1938 who reviewed eleven eases.

By 1944 this

same author had reported one hundred cases due to the administration of sulfan1le.mide alone .

Kato (70) 1n 1943

report-ea that ·this syndrome ls present in three-tenths
per eent of the patients treated with sulfapyridine.
Sulfathiazo~ and sulfad1az1ne have ·· also· been· proved
to be the cause of syndrome.
Other dru.5!.

(Curry -18).

Although am1nopyr1ne, dinitrophenal,

sulfonamide and arsphenam1ne are the most freauent
etiological agents, other drugs may be involved.

Barbi-

turates have been freouently implica ted, probably because
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o-f their unfortunate · mat.1ng · with· amtnopyrtne 1n so many
patent medicines and proprietary drug preparations.

In

almost every case the barbiturates may be · d1sm1ssed.
Goodman and Gilman (/40) believe that no case can be
traced to a barbiturate.

Cases are on record, however,

that nresent unm1staka·ble evidence that granulocytos1s
followed the adm1nistration of a · barblturate.
Gold salts apparently have been the causative
drugs in many case's~

Jackson (63) reports seventeen

over the course of six years.

·No irrefutable evidence

incriminates these drugs· but· there 1s enough evidence
to warrant caution in us1·ng them..

Quinine seems to be

the only possible etiological factor in at least five
cases.

(Franks -41).

Roentgenotherapy, radium and

thorium X nearly always produce some depression of the
leukocytes and in some cases these agents may depress
the marrow to the point of granulocytopen1a.

(Rosenthal

-105).

Mechanism of production.

The explanation o-f the

leukocyt1.c- depression in this syndrome rema.1ns incomplete.

Toxic and allergic mechanisms have been sugge·eted.

It is possible and even probable that both mechanisms are
involved.
Kracke (74) 1n 1930 noticed that most of the drugs
implicated in the p roduction of this syndrome contained
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the benzamine group.

To explain the seleetive occur-

rence of this condition in a limited group of people,
sometimes with small doses of the drugs, he advanced
the hyoothes1s that these chemicals excited the depression of the leukopoesis by acting upo-n a previously
damaged·, weakened, or "idiosyncrattc" bone marrow.
Benzene has been known to cause a depression of
erythropoests and leukopoesis e.ince the investigations
of Selling in 1916.

Kracke (74) s ays of benzene that

it is the only drug "that has been shown con•sistently
to depress leucopoests to a point of· agranulocytos1s."
Latta· and Davies (77) studied the effect or
benz·e ne in varied doses upon the bone marrow of the albino
rat.

They found that repeated daily injections of small

amounts of b-enzene in olive · ·oil produced a primary stimulatton of the neutrophtltc granulopoetic system as
shown · by an in-crease in the c1rculation ,ofneutrophiles
and hyperplasia of -the myelocyt1c marrow.

This was

followed by a rapid destruction of circulating leukocytes and an -attempt at· comcpensatiorr by hyperplasia of
the marrow.

With continuation of the benzene intoxica-

tion degenerative features appeared and ,when the benzene
\

was given in sufficient quantity comulete apla-sta ensued.
Erythro • poesis was shown to ·be more resistant than
leukopoesis.

Kracke (74) believes the depression to be
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du~ not to the benzene but to some oxidative produc t
of benzene.

~ome derivatives of ben z ene are more

easily OYidized than benzene itself,

This may be a

possible exp l an a tion for the grea ter tend ency of some
of the com9ounds related to benzene, especially the
oenzamlne g roup~ to depress the marrow than benzene it-

Testing known catabolites of benzene Kracke (74)

self.

found that when injected into rabbits, phenol, para-

cresol ,

orthrocre sol , pyro ca te chol produced no effects

while orthrobenzo i c acid 1nJeeted subcutaneously and
hyd ro quinone injected intravenously 11d produce some

depression of the leuKocytei:, .

.oenzene inject.ed into

rabbits produced agranulocytopen1a depression s1m1lar to
g ranulocytop enia.

Am111ne, oetanapthol, para-red failed

to produce any effects.

am1nopyr1ne given 1n large

doses ,five - ten grains for forty-five days) produced
no depression.

~olton (11)

was able to produce leuko-

poetic depression with amtnopyrine 1n rats.

repper (90) in 1928 suggested~ possiole alierg1c
mechanism iu 1:rhe: production of granulocytopen1~ •

.nrgumente

in favor of an a llergic mechanism are as follows :
\1)

unly a few individuals taking the drug are
a ffected.

\2)

The violen~ reaction at tne onset simulate~
aeu~e aller~ic ~neck

- 14 -

bUCD a~~~~~

f oliowing

injeetion of a foreign protein.
(3)

A neutropenia is found in foreign protein
shock and 1n serum disease.

(4)

It is not known to occur with first contact
with the disease.

(5)

A minute dose causes recorrenee of the
symptoms.

Intradermal injections of foreign protein may cause
an immediate and profound drop in _the leuko.cyte count, a
reaction which does not involve the red cells.
-105).

(Rosenthal

Typhoid vaccination has been definitely implicated

by a number of authors.

(Kracke -76).

Jackson (66)

mentions a case in which the disease seemed to follow
antttoxtn· administered.

Allergic histories are common

in patients with this disease.

These observations in-

dicated the possibility of an allergic basis.
Squier and Madison (119) were the first to explain
the effect of aminopyrine on an allergic basis.
The dramatic response to am1nopyr1ne in a susceptible
indi vldual elmula tes an allergic react·ton.

011 ·the other

hand the granulocytopenic reaction to· the other drugs
ls· slower resembling· a typical toxic reaction.

The re-

action to sulf'ona-mides usua.1 ly on-ly occurs a·f ter long
continued use of the drug one - three weeks or after large
doses have been given.

Spain (118) found an - average
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duratton o-f twenty _days and the av·e ra·g e d'o ee of fifty
grains 1n his cases.
It appears -f'rom the · work on rats done by Kornberg
(71) a depression of the bone marrow will always follow
1f suf'ftc1ent ouanti ttes· of· any of a sulfonamide 1s
given.

In this series of expertments, purified diets

· containing one -oer cent sulfathiazblt, sulfadiazine or
sulfanilamide in three separate groµps caused leukopoetlc
depression in nearly all of the rat's.

One hundred two.

rat~ were used, divided into three eoual groups of thirty0

four rats each. )

Two of the thirty-four receiving sul-

fanilamide, twenty-eight of the thirty-four receiving
sulfathiazol and twenty-two - of the rats receiving
sulfadiazine - developed severe granulocytopenia.
developed some depression.

All

Similar experiments with

sulfaguan1d1ne and sulfasuxidtne have been done with
approximately the same results. (Daft

-19).

An allergic factor carmot be dismissed in the
reaction · t ·o sulfonamides.

These• drugs sometimes ex-

hibit a.-l lergic-11ke behavior;.

Fixed drug reactions

develop after long adm1n1stration of t ·h e drug which
flare up uoon readm-1nistrat1on.

Occas·ionally a urt1cQ.r1a

will develop after the administrati on

a skin leston typ·i'cal t ·o allergy.

of the drug

-.Furthermore .-a

relationsh1p· to am1nopyrine sens1t1v1ty was demonstrated· ·b y· Kato (70) who sensitized skin to aminopyr1ne
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and was able to cause a... flare-up · when sulfonamides
were given orally.
Before dismissing the subject of etiology some~
thing should be 's aid concerning predisposing factors .•
Roberts and Kracke (103) 1n a review of eight thousand
patient·e found that one of every four had a mild
leukopen·ia·. · Among middle-aged women this number ex ..
hibittng a leukopen1a was higher - one out of every ·two
women.

This leukopenia:was postulated to indicate a

"const1tut1onai inferiority" of the bone marrow in these
1nd1v1duals.

It 1s assumed that they are more vulnerable

to the agents capable of exciting granulocytonenia.
The endocrine system has been implicated.

Sympa-

thetic simulating drugs cause a peripheral leukopenia
(e.g. adrenalin, pilOcarpine).

There has been an asso-

ciation of the onset of granulocytopenia with menstruation.

(Jackson -66, Ruskin -108, Barsburg -6).

Reznikoff'

(98) reported a case of cyclic leukopenia the cycle of

which coincided with the menstrual period.

The leucopenia

was reli·eved · durt ng pregnancy.
Before concluding the discussion of etiology it
should be mentioned that there are a few cases which
must be classified as idiopathic~

Such cases are re-

ported by Jackson (G~) and Fitz-Hugh (
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).

Pa tho lo&

Tne essential pathology according to most pathologists 1s a marked and practically complete hypoplasta.- of the myelo1d tis sue.

(Jaffe -68).

All other

pathology seems to be secondary, the result of unresisted
bacterial invasion.
Examination of the bone marrow finds · it devoid of
any' of the granulocytic tissue indu c1ng neutrophile,s,
eosinophiles, and ba.sophiles.

There - a.re no cells which

produce a positive oxida.se reaction.

The integrity of

the remainder of bone marrow is stressed.
blastic tissue may even be hyperplastic.

The erythro(Jaffe -68).

It 1s seldom affected to a marked degree. (Jackson -66-63).
In the bone marrow deprived of the myelocytic elements
there may be- an increase in the lymphopoettc centers and
small lymphocytes are present in large numbers.

Small

ly.mph folltc1es, present in small numbers- in normal marrow,
are auite eonsoicious in ttis disease.

A predominance

of plasma cells has been mentioned by some.

(Jackson -65).

There seems - to -be a diminution in vitality as well as
number of the granulocytes. · - They seem· to be less rn ob1 le
and have lost their ability to phagocytize.

(Rutledge

-109).

Though the · above ·1s the typical picture- desc·r 1·b ed
by most pa.thologt-sts dif-ferences have arisen.
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In ex-

perlmental benzene poison i ng the marrow is hyperplastic
at the level of the myeloblasts.

(Latta -33).

Others

report immature ap~earing cells with .vacuolated basophilic cytoplasm and a large· nucleus with man:, nuceloli.•
Occasionally the marrow is found to be hyperplastic in
regard to the granulocytes but that they seem to be
unabl e to escape from the marrow into the blood str.eatn.
Jaffe (68) gives a good review of the marrow pathology
in granulocytopen1a.
The next most outst·anding pathology is that of
the mucous, membranes.

In about seventy....-five per cent

of the cases there are lesions in the pharynx, fifteen
per · cent show' ·o ral lesions, five per cent show other
lesions (rectal, vaginal, vulvar, dermal, gastric,
duodenum and esonhagus ; have been reported } the remainder show no lesions. - Macros-cop1cally the lesion is a
large· bla·ck· membrane, soft and eaei l y sloughed away
with a deep ul~ rat1 on and considerable bleeding.
M1croscon1cally these lesions show a deeply extended
necros1. s ·11ot · sha.·r ply delineated from normal tissue and
without cellular res-ponse.

The tissue is pervaded

w-1th an extraordinaTtly 1-a rge number of bacteria.

These bacteria are seldom in -pure culture and show no
consistency 1n type.

Ther e are no nolymorpbonuclear

cells discernible and- ~~" plasma or lymph cells. -
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The pathology in- the rest of the body 1s varied.
It depends upon the degree of leukocytic depression and
the virulence of the organism.

On th·e whole it is the

pic.ture of an overwhelming bacteremia ..
The liver may show no gross pathology but usually
is slightly enlarged.
and hyperemic.

Microscopically it i .s edematous

The sinusoids are packed with bacteria

and there m·ay be a pertvascular infiltration with
lymphocytes and plasma cells.
central fatty degeneration.

The liver eells may show
The Kupffer cells according

to some- (Hueper -59) are increased in number.

Glisson' e

capsule, a-sis true w1th all the serous membranes, is
often teeming with bacteria.
The s-pleen macroscopically is usually slightly
enlarged.-

Microscop1eally diffused baci}r1al embol1

such as are seen in the liver~ the most commonly mentioned· pathology-. - Heupe-r (59) reports the absence of
germinative lymphocytic centers in their p,laee are
clusters ·o f ma tu-re small lymphocytes.

There seems to

be a hyperplasta of the endothelial cells.

These may

occupy as · much as ninety per cent of the total cell
volume.
The lymph nodes draining the area of mucous membranes
involved are th·e only nodes gro s sly effected.

--

enlarged and nacked with bacteria.
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These are

Hueper (59) described

an atrophy of the germinal centers and an endothelial
hyperp-l asia such as seen in the snleen.
The kidneys are usually grossly enlarged.

Again

becter1al emboli are the most common finding.
The rest of the organs are essentially normal.
Lung nathology is occasionally mentioned; a gangrenous
bronchio-nneumonia as the usual pathology.
Symptomatology and Dia~nosis
Clinically granulocytonenia resembles a fulminating infection.

The classical case exhibits a sudden

onset with a chill, followed by a high fever, headache,
and malaise.

The pulse is rapid and thready.

tration is severe.

Pros-

The patient complains of difficulty

in swallowing and a sore throat.

Soon there is a brawny

edema about· the neck with large and tender cervical lymph
nodes.

There 1s an anorexia that soon gives way to nausea

and vomiting.
Though the onset may occur during heal th some describe a prodromal period of varied length, which is manifest by lassitude, · weakness, - and a general feeling of
mala1~e.

It 1s believed that this · period cofnc1des with

the leuconenic st s te that has been shown to ' exist prior
~o the onset of the disease.
__..

(Kracke -103).

Other sym~toms a.n-d signs 1es-s frequently mentioned

- 21 •

are jotnt paints, a rash, herpes lab1a11s, ep1gastr1c -pain,
and dyspnea~

Jaundice, once considered a sine oua non

seems to oceur · 1n ·l ·e ss than one-half of the cases.
(Hueper· -19).

Diarrhea is a rare symptom .•

The oral lesions begin, typically~ as white and
yellow patches on the tonsil-s.

.Soon · these patches

become dull _ gray and· even black.

They coalesce and

spread ·rap1dl 1r to involve the entire pharynx.

Removal

of the plaques· leaves a deeply ulcerated bleeding surface.

Similar proces·ses involve the uvula, the palate,

the base ·o f· the. tongue,' and the ·gums.
pain ' is greatly varied.

The amount of

The appearance of the pharynx

1-i, by no·· means typical, and it 1 s - not poss1 ble to make
a diagnosis on the -basis of 1t .alone.
The diagno·sis depends upon · blood examinatio.n .• ·
The blood picture ls quite typical.

There is · a de-

pression of the total wh1 te count w1 th ranges from ·
three thousand ·· down to as low as five hundred.

Granu•

loeyt·es· are the first to decrease and they may completely
disappear.

There is a striking diminution of young

t-orms (a Schilling shift to the right) with many hypermature cells presen·t.
remains obseurei
are increased.

The fate of the eos1n/ph11es

Some· authors · ma1nta1n that these cells
(Rutledge -109).

are not affected.

Others claim that they

(Stillman -121).
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Most authorities

seem·· to believe that -a-11 or the granulocytes are depressed.
At first lymph·o cytes and monocytes are present 1n
their normal absolute numbers.

The entire drop 1n the

luekoeytie count . is due to the decrease in granulocytes
but as the dtsease progresses the.re · 1s an .absolute de>

crease in the monocytes and lymphocytes too.

There re-

mains, however·, .a relative lymphocytosis drug during
the entire course of the disease.

(Da.meshek -23).

( Hueper •57) •
Erythroeytes · are only slightly affected in true
granulocytos1s.

It is claimed,. however, that 1:f' the

disea-e·e last·s longer than ten days, which i •s rarely the
.I

case, the erythrocytes are depressed as well as the
leukoeytes·. · Platelet count also remains normal.
(Hueper· -57).
Further d1a·g nost-1c measures· are lnt·e res-t·1·n g but
of 11 ttle prae·tieal value·.

Bone marrow biopsy shows the

typical picture described in the section un:l er pa tho logy.
Tests for · hemorrhagie · dtast·hesis are negative.

Rosenthal

·( 105) suggests a test to determine the respon s1 veness
of the bone marrow ·in borderline cases.

In a normal

individual fU't·e en · - forty-five minutes after the
1njeet10fl c;,f •l.O m1111:gram· of· ad-rena:11n- subcutaneou,sly
one observes a ma r ked leucoe-ytie· reaction.
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This 1snot

true- in eases in -whtch- there is a compromised· bone mar-

row.
Differential Diagnosis
One of the first signs that presents itself in
this disease is an ulcero-membrane in the pharynx.

This

has leatl to eonfusion with diphtheria, fusospirocheteal
pharyngitis,· streptococcus pharyngitis and infectious
mononucleosis-.

A careful blood study usually suffices to

differentiate these ·cond1t1ona from granulocytopenia.
Certain infectious -diseases present a leukopenia
which may rarely confuse the diagnosts of granulocytopen1a.
Among these -diseases are typhoid fever, influenza,
men1ngococcal sepsis, miliary tuberculosis, kala azar,
subacute· bacterial endoeardi tts·, chicken pox, sma.11 pox-,
malaria, mea:sles, ·malta fever and · protozoan disease;- - Seldom 1·s the depres·s 1on · sufficient to confuse the ' condition w1 th·-granulocytopen1a.

It i e import!!l:nt· to ·know

that· thes-e ·d iseases · d·o· tlepres-s the · marrow so·· that· if
sulfonamides- ·or arsenicale · a.re being ·used ·in the treatment, thi·s depress ton ·due to the d1sea·s e 1·s not interpreted· as a drug reaction.
The most· f'rec,uently confused condi t1ons are acute

aplastic anem1a and a.leukem1&t'"leukem1a.

Aplast1c .

anemia runs a atn1~a. r clinical course but unlike granul~-
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cyto-oenia ·there. is a seve-re anemia from- the start ..
Typi·cally this disease shows a progressive reduction
in all blood elements, red blood cells, white cells and
platelets.

Confusion probably arises because there may

be a relatively greater decrease in white cell~.
Hemorrhages, · rare in granulocytopenia, are common 1n
aplastic anemia. On the other hand the ulcero-membrane
is less commonly present.

Aleukemic leukemia produces

more difficult differentiation.

The uniformly bad

prognosis in aleukemic leukemia makes the differentiation
I

imperative in evaluating the~apy.

The onset of this

disease is not Quite so abrulpt at that of granulocytopen1a.

There is a generalized hemorrhagic d1asthesis.

ThP blood picture is usually diagnostic.

In aleukemic

leukemia there is a predominance o·f immature cells,
myelocytes, young lymphocytes and myeloblasts which are
in contrast to the hypermature cells of granulocytopen1a.
It should be borne in mind that acute leukemia is a
disease of childpood and early adult life.

In the leu-

kemias there is typically a splenomegally and generated
lymphadenopathy.

A sternal puncture may be necessary 1n

borderline cases.
Prognosis
The most aecurate esttmate ot the prognosis is
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that of Jackson (63).

Be found a mortality of ~eventy-

eight ner cent among untreated patients • .
The prognosis seems to depend to some extent upon
the ca.usati ve agent.

A high percentage· (ninety per cent)

of the seventy-five untreat ed patien ts 1n Jackson's

survey were am1nopyrin e induced .

There seems to be a

muchhtgher :percentage of recoveries among the arsphenam1ne-1nduced granuloeytopen1a.

Smith (117) reports a

forty-five per· eent spontaneous recovery in these patients .•
Other ·authors agree. (Taussig -124). (Kracke -73).

On

the other hand sulfonamide-induced granulocytopenia appears
from recent re-oorts to be more refractory to treatment than
that due to either am1nopyr1ne or arsphenam1ne.
Earl·y invest·igators believed · that the number or
per1nheral ·leucocytes could be used as a prognostic
measure.

Friedemann (44) reported a much higher percen-

tage of -cures · among tho·se who ' had one thousand cells or
more than·· those ·whose· ce11 level was below this number
in his ser1e·s t·rea t-ed with Ro-engtenotherapy.

In a ·

critical survey of patients treated with pentosenucleotides Jackso·n and Ro·b erts ( 65) contradict this, maintaining that the number ~f circulating leukocytes at an
onset of the disease have little or not prognostic value.
Ten per c-ent o-f thei·r ·eas·es had· leukoeyte levels lower
than five hundred per cubic m111lmeter.

Sixty per cent
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--------..."-...

of these cases recovered, a percentage which d1d not
differ materially from the overall recovery rate (seventy per cent).
It appears from their report that the percentage _
of neutrophiles also is of but little s1gn1flcance.
Thirty-fl ve per cent or the sixty-nine cases repo·r ted
by these authors had no granulocytes!

Seventy-six per

cent of these recovered.
The persistence of a high percentage of monocytee
1n the blood during the course ·of disease or -the early
reapuearance· of these cells under treatment seems to be a
prop! t1ous prognos·t 1c omen.

Occasionally there is a

monocyt·o·s 1s ac·company1ng the disease.

(Rosenthal and Abel

-104) reported twenty.;.two patients with an elevated
monoc-yte count, seventeen (seventy-seven per cent) of
which recovered.

The appearance of myelooytes usually

i ndicates ensuing recovery.

(Madison and- Sou1er -119).

The cl1n1cal picture, too,. seems to .be of 1ittle
value in determ i ning the course and outcome of the disease.

The- height of the temnera ture, one· of . the most

tangible clinical signs, is or no value.

(Jackson -66).

In fatal cases death usually occurs-- wlth1n two ·..
seven days of the clinical manifestation of the disease.
-Mere absence or leukocytes ' for fou·r - ·seven days is
incompat1.ble with 11f e.

The ave r age life of the white
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cell 1s three - four days.

Recovery 1s usually c·o mplete

in two - weeks 1n· those cases in which the disease takes a
favorab1e turn.Theran
.General considerations.
The firs--t consideration 1n any system of therapy is
prevention~

The most- obvious preventive method is the

el1m:1nat1:on· of noxious therapy.

This is quite posei ble

and certainly advisable regarding the use of such drugs
as aminopyrine, gold salts,· d1nitrophenol~ and other
therapeutically unimporta-nt chem-ica·ls.

Arsph-enamine and

the sulfonam1:des present a problem, however·, · since these
drugs play such an important part in modern medicine.
Hence· other prev·ent1 ve measures must be looked to.
Madison and Squier (119) claim that if the disease
is diseovered within twenty-four hours of the onset of
the granulocyt·ic depression, a simple cessation · of the
adm1n1stration · of' the drug will result in a high percen:
tage of recoverte·s~

The implication is that daily leuko-

cyte counts would be· invaluable- in all pa-t1ents rec·e1v1ng
sulfon·a.m1.de therapy.

This, of course-, is impracticable..

It mtght be, h·owever, if Kraeke (see etiology) has
found a group of individuals predlspo-sed to granuloeytopenia that eere(µl ~ttent1on to this group only woul9
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possibly prove to b§,.. a solution to this problem.

There

1e a higher· percent-age ·of spontaneous reoove·r 1es among
arsphenamtne-1nduc·ed- -granulocyto-p enia and the one-et is
- not · so abrupt · as seen 1n am1nonyrine- or sulfonam1de1ndueed ·granulocytopen1a·.

For those recetvtng this

drug - weekly blood counts -would seem to be suff1c1ent even
in °the "predisposed"- group of ind! viduals.
A history of having had .a leukopenic reaction to
these drugs ·should nreclude their adm1n,.. ·stratton· except,
of course, 1n those pat1enta tn whtch the use of the
drug· is- 1mpe-rat1.ve.
When the disease once becomes manifest there are
certain supporting· measures which would seem to increase
the percentage of recoveries.
mea-sures are :purely empirical.
evidenc-e proving their worth.

(Beckman-/~).

These

There is no statistical
Fluids may . be forced in

an effort- to · r1d the · body of · the toxic agent.

It is

often imposs·1 ble to force , fluids orally because ·of. the
painful pharyngeeal lesions. · Any of the parenteral
routes may- be us-ed-~
1n all ca ses by some·;

Intravenous · f'lu1d·s are suggested
(Ha·ll ·-49).

A high carbohydrate
'Y

diet seems to be indicated. (Beckma·n -/~o).

Because

of a weakened heart it is sometimes advisable to use
heart stimulants - cafftene or coram1ne.
Local therapy has receiv-ed undo attention.
best local therapy is the one which does the least
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The

harm to the healthy 0,ssues.

Potassium chlora~e,

copuer sulfate, a-rsphenam1ne powders, iodine, organic
iodides and a number of orga.nic mercurial compounds
all have been suggested.

None is of therapeutic value.

If, as 1s often the case, the foeteror1s becomes un-

bearable, freauent · spraying of the lesion ·with some
ox-idizing agent hel.,..,s eliminate this symptom. - A
saturated solution of potassium chlorate followed by
cop"9er sulfate or saline· gargles may be used.

(Beck -7) .•

Excision of necrotic material . or incision into sup- ·
posed suppurated -areas is of no value until the patient
begins -to recover.

There are no abscess ·formations 1n

gra.!11:1locytopen1.a unt11 the onset of recovery.
\

Spec·ifte· t·herapy.
Few indisputable~ conclue-tons · can be drawn regardtng
the efficacies of the so-eal led "specific therapies·" of
granulocytopen1:a·. · Many methods have been advanced, some
of which have stirred- up considerable enthusiasm but
none has had universal acceptance.
Blood tra·nsfuerion. · Trans'f"usion of blood wss the
first therapeutic measure -advanced and probably has been
the m·o st nearly universally accepted one.•
Proponents of tran·s fusional therapy are numerous.
Finnigan (35) wa s probably the first to use transfusions
in this country (1927)-.

Reye ·(96) reported ·o ne year
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later a patient in which~ a transfusion was followed by
a sharp rise in the granulocyte count and recovery.
Dwyer (33) in the same year reported a favorable res-

ponse to transfusions.

Hutchinson (60) and Meyer (84)

( 1930) believed their recoveries were due to transfu- ..
sion therapy.

Horn (56) in the same year in a review of

therapeutic methods maintained that blood transfusions are
"the only therapeutic methods which have met with success."
Taueelg (124) in 1931 in a review of thirty-three patients
treated wi·t h blood transfusions, reported a recovery of
thirty-six per cent.

At this time the recovery rate of

untreated eases was between ten and twenty per cent.
More recent endorsement- of· transfusional therapy 1s
that of Jackson· (63) who in 1939 wrote "unquestionably
some reeo'V'eries have depended u'!)on the administration
of transfusion."

Kracke (73) as recent as 1944 recom-

mended transfusions in his course of therapy.
On the other hand many investigators deny the
value of transfusions.
be of little value.

Wyatt (137) believes them to

Stillman (121) maintains that they

are of no value as does Reznikoff (100) who shows the
mortality · to be as high with tranefus1one as without~
Proponents of transfusion therapy· have .used them
chiefly on an empirical basis.

Thought 1t is nowhere

stated it may be, assucrred that their contention 1s that
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it supplies the missing leukocytes.

The number of

leukocytes gtven in the ordinary transfusion, however,
is small.

The total blood volume of the average sized

male 1s a little over six liters.

The common transfu-

sions used in the treatment of granulocytopenia are
three hundred - five hundred cubic centimeters of blood
given every other day.

At the most, this would add only

one-twelfth the number of white cells ordinarily present
in the body.

Moreover it has been demonstrated that the

bulk of the ·leukocytes necessary to ·combat an· infection
are held within · the ma-rrow and along the endothelial
lining of capillaries.

(Clark -15a).

present in tra-nsfused blood.

These are not

Disregarding these factors

1t still remains to be proved ' that ·leukocytes once transmitted retain · the1r anti-bacterial pronerties.
There· 1s evidence· to· indicate that the transfusion
of blo-0d depresses -the bone marrow. · Beck (7) and
Jackson· (66) point to the eryt-hropoetic depression of
transfusions- and believe that · thi-s might as well apply to
leukopoesis.

Reznikof'f' (99) believes that at least large

tran·sfusion-s definitely depress the bone marrow.

Jacks,a:n

(69) points out in · ·his series of eases (1931) that 1n every

one in which ·transfusions were given there followed 1n a
few days-- a. def'in1 te drop in the wh1·t-e count ·regardless

eo1nc1denta l therapy.

He also shows· that in patients

- 32 -

or

suffering from chronic ap,l·astic anemia and treated with
repeated transfusion, there is often a depres·sed leukoeytic count.

That this depressLon is not always severe

is evidenced by the report of Weber (131).

This author

reported a patient treated five years with well over
one hundred transfusions (1n treatment of aplastic
anemia) who had no marked leukope.nia.
It has been suggested that the blood of normal
individuals contains a maturation factor absent in the
patients suffering from this syndrome. · ( Beck •7).
Most observers believe that if this be present it
probably is in too small a quantity to be .of value.
The use of large transfusions has been condemned
by Hal·l (49) on the basis that this will place a load
on an already w·e ak·ened myocardium.
The most recent comprehensive study of the value of
transfusta.-1 therapy· 1s that of Jackson (63).

This

author found seventeen patients 1n which blood transfusion was the only therapeutic measure.
a mortality rate of eighty-four per· cent.

Fouteen died,
Fitty-si.x

patients were treated w-1 th ·transfu·s 1ons combined with·
other therapeutic met hods.
three per cent mortality.

Of these there was a fiftyA large percentage of these

were also treated w1t.h pentoee nucleotide, whtc·h by
1 tself, in h1 s seri~es~ was -therapeutically effect! ve.
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If the effect of the pentose nucleotide wa s excluded,
the mortality rate was a.bout seventy-four per cent.
H1s obvious conclusions were that transfusions a re at
best a poor therapeutic· measure.
Ci tra. ted and who-le ·fresh blood both ha ve been
used with equivocal results.
Transfusions a.re not' wholly w1 thout value. however,
for there ma:y be· oomp11cat1ons whlch are in themselves
1nd1cBt1ons for transfusion.

( e. g. Secondary anemia - .J,

unrelated to the disease proper.)

Dayton (28) contends

that 1n cases of excessive bleeding,a rare symptom or
this d1Erease, tran sfusions are valuable.
The conclusion seems to be that transfusions have
little or no ~alue in the -treatment of granulo cytopen1a
per se and may possibly · be deleterious-.

There are,

however, complications which may ·be bentfited by transfus-1onal therapy'.

These are the only 1ndica tions for

its use.
Roentgen·otherapy.

This therapeutic measure was

introduced 1·n 1927 by Frledemann (144).

In his initial

repor-t he- called a·ttention to four pat1ents which
responded 1mm·e d1a tely to "stlmula ting" d-oees of
Roentgen rays over the long bones.

The following year

he added to· his · ser1e-s•" of cases two more survivors,
but simultaneously, four· failures.
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In three of the

four failures the disease was fulminating and the
patients died within twenty - hours.

These would be

eliminated from consideration in the usual methods of
evaluation of therapy.

Some years later he reported

upon forty-three patients treated exclusively by
Roentgenotherapy.

Five of these died within the first

thirty-six hours and may be excluded from considera.tion.
There were thirteen permanent cures and twenty-five
deaths of the remaining group, a mortality of about
sixty-five per cent.

All of - these patients exhibited

a profound leukopenia averaging eight hundred - fourteen hundred leukocytes per cubic millimeter.
Waters and F1ror (129) ha.v e done much experimental
study on the effects of Roentgenotherapy. · These men
report successes in their patients.
therapeutists · have had ·s ucc·e es.

Many other

(Hutchinson -60,

Hueper -19, Naucber -88, Doan -31).
Friedemann suggested one-twentieth of an erythemat,ous dose, ·hie selection based upon the ArnthSchultz law that ~small doses stimulate, large doses
destroy."

Other Roentgenologists consider this a

fortunate ·selection and · has been the standard dosage
since its· introduction. (129-).

In order to obtain this

doaage· Waters· and F1ror ·(129) used one hundred thirty
thousR.nd - two hundr-.e d- thousand vol ts at skin distance of
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r1rty centimeters, port .9..f thirty centimeters through

one millimeter of aluminum and five-tenths millimeter
of copper.

It is the common practice of the Roentgen-

olog1sts to give the treatment over- the long bones and
occasionally the ribs.
A typical response to Roentgenotherapy is described
by Kaetlin ·(69).

The patient selected had an initial

white blood count· of five hundred cells per cubic milli-

me·ter ·alm·o st· a·ll lymphocytes.
given over the long bones..

The above dosage was

In two hours the leukocyte

count had risen ·t o eight hundred cells per cubic
m111imet~r-, 1n eight houre·--"'to seventeen hundred.

The

next day ·the count· was found to be thirty-eight hundred.
A second · treatment- was given on ·this day and a few
h·ours later the- c·ount had moun·ted to ninety-two hundred
cells per cu·b ic millimeter.

The patient was dismissed

a few days later~ cured.
The response in those· who recover seems to occur
wt th·i'n thirty-six ·hours.
Those who advocated Roentgenotherapy postulated
a stimulation of leukopoesis with small "stimulating"
doses or Roentgen rays and potn·ted to the almost
immediate· per1nheral· leukocyt-osis as, proof.

That

Roentgen ray produces a · ,:,er1pheral leukocytosis is
undeniable.

The le).lkopenia of typhoid fever resp·o nds

· - 36 ..

quickly to this Roentgen ray exposure.
Firor -129).

(Waters and

These same authors reported a leukocytoeie

in almost all of their patients with granulocytopenia.
The mechanism of the leukoeytic response is, however,
under auestion·.

This pointed out that adult marrow 1:n

the sites irrad1cated have lost their leukoJ:llltic function
as well as their erythropoetie.

Proponents postulate a

reactivation of latent myeloplastie .centere scattered
throughout the adipose bone marrow.

It ls true that

und-er physiologic-al strains (e.g. chronic anoxemia)
and in certain pathological states (e.g. the leukemias)
these centers do become active but there is no proof that
they do so 1n granulocytopenia under Roentgen ray
"stimulation-. 11

Waters and F1ror (129) contend that there

1s no evidence t ·o indicate that Roentgen 1rrad1at1on has
any effect on any cell other than to destroy it.

Doan

(30) assuming thi·s to be correct suggested that the
Roent-gen · ray might· cause tissue destru·ction w1 thin the
marrow; the produ eta of this destruction, he asserted,

might act as stimulants to 1eukopoesis.

Beck (7) be-

lieved it to be essential that large areas of the whole
body are trradicated suggesting that this stimulates
some- interna l organ to secrete a hormone necessary for
the maturation of the leukocytes.
Jackson (66) would dism iss the whole contention of
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myeloblast1c stimulation from Roentgen ray exposure.
He point·ed out that it ordinarily takes four tie five days
for the development of a mature leukocyte from a myeloblast (the state at which the cells are arrested).

It

is unlikely that this brief exposure to Roentgen ray
could increase the rate of production of leukocytes
enough t-o account for the dramatic apnearance of
peripheral leukocytes as seen in those _patiente receiving Roentgen ray treament.

The explanation of

this peripheral response lies in a redistribution
phenomena, perhaps a release from the endothetical wall
of capillaries of internal organs where they are known
to be in abundance.

Whether mobilization of these cells

1s of value or not seems to be .an unanswered question.

Recent report~ on the eff1eaey of Roentgenotherapy
are at the best disappointing.

Since 1933 there have

been five cases treated with Roentgenotherapy exclusively.

All but one died.

K-r ac·k e {50) wrote,

"Roentgen ray therapy which s.eemed early 1n the
disease history to be of und1sputable value has proven
to be only of temnorary ·value usually a relapse and
death occurred within two months." ·
A recent report of twenty~two cases (Jackson

-63)

treated with· Roen·tgen · ray and other therapeutic methods
shows fourteen deaths;

a mortality rate of sixty-four

per cent.
In conclusion it- appears that Roentgenotherapy
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tnough i t produces a te!!!,Pora.ry leukocytos1s 1s of little
. 'ii

permanent value in treatment of granulocyto~enia.
The derivatives of nucleoproteins.
Nucleoproteins are vague chemical substances de•
rived from the nuclei of cells.

Chemica1ly they seem to

be a loose combination of nucl£1c acid and some baste

protein such as protamine.

Fractional hydrolysis will

yield a series of products as illustrated below:
Nucleoprotein

I

t

Protein

t

Protein

Nuclein

i

I

Nucleic acid (thymonucleic acid)
Four Nucleotides

I

'

{Four) Phosnhoric ac1dS

{Four) Nucleosides

'
I

(Four) Bases

{Four) Carbohydrates

I

'

-,1

{Two) Purine

(Two) Pyrimidine

Adenine

Cytosine

Quanine

Thymine

The effect of__the derivatives o·f the nucleoprotein
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on the blood was suggested long before granulocytopenia
became recognized as a disease entity.

On a purely

emperical basis nuclein derived from pus cells was used
as early as 1893 by Vaughan (128).

It was asserted by

this author that it would "increase the germicidal power
of the blood in diseases or microbi e organ."
renorts were those of Ames and Huntley (2).

Other early
Sodium

nucleinate was first used to produce leukocytoeis in
man by Neymann in 1917.

(87).

The leukocytic response

following this early treatment with nuclein was not of
sufficient ma:t: !'. nitude to affect the course of a disease.
The rise was not much greater than that seen in the normal
fluctuations in leukocytio level through out the day.
Clinically it proved to be of little value.
Nucleotide therau.

Jackson (65) was the ftr,s t

investigator to publish a reuort on the use of nucleotides
in the therany of granulocytopenia and he is generally
accepted aa · the o:r1g1nator- of th i s method of therapy.
Iu n1s 1n1t1al report he reviewed tne treatment. of
tnree cases of ~y- 1cal granulocytonen1a along witn five
cases of mal1gnan~ leukopenia - a result of overwhelm11ng
infection - and two cases of extreme aplaetic anemia .
due ~o benzene poisoning.

~even of the thirteen pat~ents

suffering from true granu1ocytopenia recovered
(two of which nad relanses out these responded well to
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reapplication of therapy).

Another recovered a normal

blood oicture but suffered a fatal pulmonary hemorrhage.
Four of the seven cases responding to treatment had no
granulocytes.

Hemotologically there was no difference

between the patients who r esponded and those who did
not.
Soon after 1 ts introduction the pentose nucleo·tides became the m·o st popular therapeutic method.
Jackson "(65) 1n 1932 - one year after his first report
reviewed sixty-nine cases of granulocytopenia 1n which

there were fifty- one recoveries, a mortality rate of
twenty-six per cent, which was up to that time by far
the l .o west mortality · rate reported.
Jackson used Nucleotide K96 in the following dosage.
In acute cases seven-tenths gra~s of Nucleotide K96 ·
were· disso-lved in one hundred cubic centimeters of physiolog1eal saline solution and was injected intravenously
daily for four days.

Seven-tenths grams in ten cubic

centimeters of distilled water intermus·e ularly also
given daily was injected simultaneously
for some time · fo1lowing improvement.
tendency to increase this amount.

and eontinued

There has been a

One and four-tenths

gram in one thousand cubic centimeters intravenously

for four days and at the same time seven-tenths grams
three times a day trf'trllmuscularly for acute cases.
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The

latter dosage was used .1-tJ most of Jackson's more recent
patients.

If there were no response in ten days, con-

tinuation· of therapy is valueless.
The type and time of the hema~ological response is
quite uniform and· characteristic.

Occasionally there

will be a few granulocytes apnearing within forty-eight
hours but this is the except.ion and· the rise is neve-r
· definite·. · Typically the rise is between the fourth to
seventh· day usually on the fifth day, a time which -it
is interesting to note - corresponds with the re_t1culocytio rise following· liver· extract in pernicious
anemia.

This response does not se-em to depend up·o n · the

length· of time · t-he- nat1ent he.d suffered the disease
pri·o r ·to a'dm1 n1stration of therapy-.

The average

dura·tion before t-he treatment in Jackson's series was
seven and seven-tenths days.

In favorable cases the

first· sign- o·f improvement 1s the appearance
myelocy-tes.

or

young

Thes-e- may - reach as high as a level as

illen ty per ·cent bef-ol'e ·they are· replaced by the more
mature neutrophilie- elem'e nt •
Clin1·cal improvement c1os.ely coincides w1 th the
hematologica-1 response.

One should not be discouraged

by the absence o·f 1mmed,1ate cl1n1ca1 response·.

Fre-

quently the patient becomes progressively -worse until 'the
hematolog1eal response 1s manifest.
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The temperature

usually returns to normal within forty-eight hours
of t he return of the normal blood picture a.nd may even
precede the peripheral hematological changes.
Immediately following the intravenous administra- tion of pentose nucleotides there is usually a sharp
temporary rea,ct1on cha.ra.cterized by dyspnea, prechordeal distress·, bradycardia and perspiration.

This

reaction occurs frequently with intravenous injections,
and is au1 te distressing at times-.

With intramuscular

- injections · .the reaction 1s much less common and seldom
severe.

Hence the latter is preferred if the case 1s

not ·too far advanced·.

Other symptoms of chills, pruri-

t1s, anpreh-enslon·, fatigue and cerebral symptoms of
confusion, listlessness, and lethargy oc·caslonally
follow the a:dm1nistratton· of this drug.

These are

only trans,:tent and are usually gone · at the end of an
hour. · The patient may descr1·b e a "tight feeling" around
the heart follow·ed by a le-t·-down feeling that might
develop into a semi-comatose· state.

(Dameshek -22).

Occasionally a steril~ abscess may develop at the
s1te · or the . injection.
Contraindications to the use of the - pentose nucleotides are rare.

Jackson (66) prefers not to use the

drug 1n patients in which there ts a marked cardiac decompenea·tion or-irthose patients who give the history
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o~ anaphylact1c reactions. ·
Rationale.

It was suggested by Sabin (110) that

the normal "zonal" range of leukocytes is maintained
by a constant stimulus derived from disintegrating
cells of the same type~

Reznikoff (99) points out

that these disintegrating cells contain nucle.oprotein
and contend that it might be that these or their decomposition products which cause stimulation of the

marrow.
Beek (7) believed that among the various substances known to cause leukocytosis - adrenalin, pilocarpine, foreign protein, et cetera, nucleic acid is
the most likely to play a part in the n·ormal mechanism.
It is interesting to note that the first nucleic acid
used 1n an attempt to induce a leukocytosis was that
derived from "nuclein" which was in turn derived from
"pus."
In one of the first laboratory examinations of the
effects of nuclein Do·a n ' (30) 1-n 1928 injected sodium
nucletnate intramuscularly into rabbits, r~sulting in
·every case in a deftn1 te and constant leukocytosis.
Jackson ( 67)

in 1924 dem·onstrated· the - presene-e

of pent·ose nucleot·ides in human blood • . Doan (30) tested
the effect of these chemicals upon the leukopoet1c system
of rabbits.

He injected these animals with pentose

nucleotide

in gradually increasing doses (from fifty
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milligram to one gram daily}.

After a preliminary

leukopenia of several hours duration, following the
first 1njectioff, there was ·a definite and constant
leukocytos1s.

Autopsy findings showed myelocyttc hy-

perplasia in the bone marrow.

No abnormalities except

the finding of aberrant myeloblastie centers ln the
liver spleen and kidney.
The transient leukopenia following pentoee nucleotide injections seems to be a result of "increased
gra.nulocytie activity" of the spleen.

Thts short de-

pressed pha·s e was irradic4 ted by splenectomy.

Adenine

and aua.-nine, hydrolytic products of nucl·eottdes do not
produce this inittal leukopenia depression.
The mechanism of the renewal of leukopoetic
activity is obscure.

'Beck (7) postulated the existence

of a maturation fact.o~wh1ch is necessary for the development of mature granulocytes from myeloblasts, and a
ehemotactic factor necess9.ry for the deliverance of
the -mature cells into the vascular system. · The former
factor is compared to the factor in liver extract necessary for the maturation of red cells.

The nucleo-

t1des are assumed to be either· a chemotactie or more
probably the maturation.
That the nucleotides can prevent the depression of
the leukocytes has been dem·o netrated by Ruskin (107) 1n
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1943.

Diphtheria toxin was injected into a series of

laboratory animals in sufficient quantities to cause
death.

This same amount· of toxin was tn·jected in'to a

comparable group. of animals and given simultaneous
doses of manganese nucleotides.
caped death.

These animals all es-

The death in the first series was the re-

sult of leukopenic depression and a hypoplastlc marrow
was demonstra ted on biopsy.

The second series displayed

a normal leukocytic reaction •
The leukopen·ias of typhoid fever seem to react
favorably to nucleotide therapy.
Jackson (63) made an ex t ensive survey of the patients
treated by nucleotides between the years 1933-1939.
Forty-one cases were trea ted by pentose nucleotide alone.
Of this series of cases there was a twenty-nine per cent
mortality rate.

Among those treated with pentnucleoids

along with other tynes of therauy there was a forty per
cent mortality tn forty-four cases.

It was his conclusion

that pentose nucleotides is a valuable therapeutic agent.
Results have not been uniformly ~ucceseful, however, pa rticularly of late.

Dameshek (24) . reports

comnlete failure 1n most of his cases of the last few
years.

Hall (49) reports unsatisfactory results.

Failure in nucleotide therapy has been ascribed to
many causes.

Rusk in (107) believes that cu rrently used
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pentose nucleotides represent a mixture of adenine and
guanine nucleotides in uncertain proportions.

Guanine

nucleotide is easily hydrolysed and adenine nucleotides only with difficult.

Because of this often pen-

tose nueleotides show a predominance of quanine nucleotides and some preparations show no adenine nucleotide.
It has been demonstrated that while adenine nucleotides
have a mgrked effect in raising the leukocytic count
g~anine nucleotide has little or not effect.
-107).

(Ruskin

This has been suggested as a possible cause

of certain failures.

Another possibility is that the

difference in etiology since 1937 may be responsible
for the largest percentage of failures.

Most of the

recent cases have been the result of sulfonamide instead
of aminopyr1ne therapy, the most frequent offender prior
to that time.
Nucleotides seem to have a beneficial effeet upon
the course of some cases of granulocytos1e.
Adenine sulfate.

Reznikoff (100) first used adenine

sulfate in the treatment of granulocytopenia (1928).

By

1930 he had reported on the treatment of fifteen cases
in which he had eleven recoveries. Reznikoff used one gram of the pure salt dissolved
1n forty cubic centimeters of normal saline.

It was

necessary to dissolve this relatively insoluable salt
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1n boiling wa ter and administer it intravenously while
it was still warm in order_to prevent prec1p1tat1on.

This

dosage wa s given three times a day for three days.
Richmond · (101) maintains that adenine sulfate ls best
dissolved by adding enough ten per cent hydrooloric acid
to one gram in . one hundred cubic centimeters of boiling
saline.

'l'his mixture is slightly irritating and must

be given slowly.

It is only given intravenously.

Adenine sulfate differs from pentnucleotides in that it
produces little or no toxic reaction.

This is an esDecial

advantage in giving intravenous medication.

Dameshek

reported giving the drug in two hundred consecutive cases
in which he had but two mild reactions.
The speed of reaction is more rau1d in aden i ne
sulfate than 1n pentose nucleotide therapy.

A response

usually occurs within twenty-four hours giving it espectal value 1n severe cases.
The rationale of aden1ne sulfate therapy closely
parallels or may be identical to that of the pentose
nucleotide.

Buell (13) showed that adenine sulfate is

present in normal human blood, probably inthe form of
adenylie acid.

Careful analysis failed to reveal the

presence of guanine, free or combined.- ·Thie investigation also failed to identify any of the other nucleotides or their deco ~pos1tion produets.
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Adenine could

not be found _w1th1n the cell body itself.
Jackson (63) renorted on the treatment during the
1930's of ten patients with granulocytopen1a.

Six of

these received adenine sulfate alone, four were treated
with adenine sulfate plus other methods.

Of the six

treated with adenine sulfa te alone, there_were no deaths.
There were two deat hs among those treated with adenine
and other tre?. tment.
Guanine as mentioned above has but little stimulating effect unon bone marrow and has not been used except
in isola ted cases.
adenine.

Guanine is a purine compound as is

Compounds havin g a purine base have been shown

to stimulate the leukopoet1c system.

(Ruskin (108).

The other two nucleotides in nucleic acid have pyrimidine
bases, examnles - thymine and cytosine.

These comnounds

have a depressing instead of a stimulating effect upon
the bone marrow.

In nucleic acid these two are some-

what balanced against each other explaining the rather
benign effect of this drug, as contrasted to the ma rked
effect ~f the isola ted aden t ne nucleotide.
Liver thera_El:. The use of liver therapy in the
treatment of granulocytopenia was introduced by Foran
(139) in 1933.

Martin ( 69) the following year treated

three pa.t1ents and had un-1versal r:ecovery.

At -the

same time he renorted five other cases treated with equal
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success.
Foran (40a) injected the eouivalent of one hundred
grams · of liver (using the fraction "G" of Cohn) intra.venously or intramuscularly every eight hours until
there was a definite rise in granulocyte -and clinical
improvement was manifested~

This was accepted for

standard in most of the early treatments.

Martin ( 83)

used three hundred grams orally or its eouivalent in dried
yeast nlus the· intramuscularly admtnistra tion of the
equivalent of twenty gram·s of liver daily •
Murphy (86a) reports a promp~· and often shock-like
response in the - number of leukocytes after liver therapy.
Other authors who mention this response point out that
there is also a definite tall in the leukocyte count
in about eighteen hours.

They

are inclined to think

that the shock-like response is a manifestation

or

peripheral redistribution re.ther than actual stimula. tive.
Rationale.

It was argued that liver contained the

ma.turatton 'factor· for-- the developm-ent of wh1 te blood
cells.

(Beek- -8).

He po1nt·ed to the elevation of

the leukocyte count in those patients receiving liver-in pernicious anemia.

Jackson (63) believes the leuko-

penia coinci'dent to pern1ctous anemia to be due to
the repla.eement
tissue.

or

myeloblastic tissue with erythroblast1c

When the maturation factor ls supplied by the
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liver, the erythrobla~t1c tissue recedes leaving more
room for leukopoetic tissue.
Beck (8) is inclined to believe th B.t if a. leukonoetic
maturation factor 1s present it has not been properly
extracted.

Hunter (61) describes a case of granulocy-

topenia which developed using the course of liver therany.
Liver has been shown to be h1gh in nucleotides,
which chemically resembles those known to cause leuco,t osis.

It is quite uossible that the resoonse may be based upon
this const1tutent.
Daft (19) was able to protect rats fed one per cent
sulfaguan1dine or sulfasux1dine against the develonment
of granulocytopenia.

In rats in which the depression

occurred (those not protected) therapy with intravenous
liver extract caused a definite and constant increase
in granulocytes.

B1onsies of the marrow during the

depression showed a decrease in the myelocytic element.
After the liver therapy the bioosies had returned to
normal.

thiazol,

Kornberg (89) had similar results- with sulfasulfadiazine, and sulfanilam1de-1nduced

granolocytopenia.
Jackson (63) 1n the most recent survey of liver
therapy recorded the recovery of seven out of ni~e
patients treated exclusively with liver.

In seventeen

patients in which liver therapy was combined with other
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therapeutic methods fourteen died, a combined mortality
of 62%.
Yellow Bone Marrow. Giffen and Watkins (49) in 1928
while studying the effect of yellow bone marrow on ·
patients with "secondary anemia" observed a moderate increase in the number of monocytes and neutro!)hiles.

This

suggested the use of this drug 1n the therapy of granulocytopenia.

They flrst used the drug for the treatment

of this syndrome 1n 1930.

The first case was successful.

Later Marberg and Wiles {82) reported on the results of
the adm1nistration ·of this form · of therapy to twenty
patients, thirteen of which suffered true granuloeytopenia, the diagnosis of the other seven being dubious.
In the cases of true granulooytopen1a there wa·s uniform
recovery.

Other reports of the successful use of this

drug are those Of Hunter (61) and Jackaon (63).
The drug was first administered in the form of
crude desiccated yellow bone marrow. (Giffen and Watkins - 49).

It was necessary to administer 300-500

grams of this material, which proved to be unpleasant
to take.

This crude marrow wa-s somewhat concentrated

and placed into three and one-half grain capsules.
(Hall - 49).

It was neceesarv to· administer 50-200 of

these -capsules daily.

Giffen and Watkins recommend

continuation ·o f the above- -therapy until there is a

- 52 -

completely normal bl ood ~pJcture.

Ai t.er which tney ad-

vise cont1nutng w1tn one-tn1rd to one-nalf of tn1s dose
for tnree to four months.

Tilere 1s now another prepar-

ation from the unsapon1f1able portion or yellow bone
marrow- wntcn ts red1sso'lved 1n a bland 011. (Maroery
and Wiles - 82).

One drop of this preparation is

equivalent to two grams of marrow.
In response during recovery the first cells to
increase in number are the monocytes, usually within
48 hours.

These may reach a percentage of ten to twenty

or even as high as forty.

(Giffen and Watkins - 49).

Following this rise is an increase in polymorphonuclear
neutrophiles, usually the more immature forms, promyelocytes and myelocytes are frequently observed.

The total

leucocyte count may quick l y regain normalcy, and even rise
I

above normal but the recovery should not be considered
complete until the eosenophiles and basoph11es, which
are slow in responding, have appeared.
Again the rationale allegedly depends upon the
presence of a maturation factor. · Li.ttle work has been
done to isolate this factor, except that it seems to be
in the unsaponifiable nortion of the marrow.
The results have been quite satisfactory.

Besides

the above report of Marbery and Wi l es, Giffen and Watkins
had by 1938 treated twenty-four pat ients with yellow bone
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Though no comulete report is available, they report
Jacks on (63) r eported on ten patients

excellent results .

.treated, four with yellow bone marrow alone in which there
was 100% recovery, six with yellow bone marrow in addition

to other therapy.

In these cases there was 17% recovery.

It apnears that yellow bone marrow is of definite
value.

However, not a sufficient number of patients has

been treated to warrant a definite conclusion.
Leucooytic cream. The treatment of granulocytopen1a
with leucocytic cream wa·s introduced in 1936 by Strumia ( 120).

He postulated .t ha t leucoeytes, given intra-

muscularly, would disintegrate releasing de-r1vatives
of nucleic acid.

These derivatives would be specific

in their stimulating effect upon leucopoests · arut. w-ould
be more tolerent to the patient than such der1vat-1ves
othe-rwlse obtained.

Using the leucocytic cream derived f-rom centrifuged
citrated blood. he trea·ted ten cases of true granulocyto-penia.

In most cases ·there was- a leucocytic response

within forty-eight hours.

Usually three to :fbur in'
ject1ons su-f f1eed to bring about improvement in both the

clinical and hematological pictures.

The results in

this series of eases appears to be uniformly good.
Sulfonamide thera,E.I. Since the advent · of the sul•
fonamide·· drugs the mortality rate of granuloeytopenia
has ·b een steadily increasi ng.
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Sulfonamide induced

granulocytopenia appears to be refractory to any form
ofpreviously efficacious therapy whtether 1t be pentose
nucleotides, yellow bone marrow, leucocytic cream, a
liver extract.
Dameskek (24)

contends that the immediate cause

of death in granulocytopenia is an overwhelming in~
fection.

He suggests that even 1n sulfonamide induced

granuloeytopenia these drugs be continued to combat
the infection 1n spite of the depression of the leucocytes.

The hope then is that the sulfonamide will tide

the patient over until the marrow begins again the production of white cells.

This author use~ this form

of therapy on two patients - with euocess.

He suggests

the continued use of pentose nucleotide·s during the
treatment.
Miscellaneous 'lberapeutic Measur~s. Although other
therapeutic. measures may not have had sufficient trial,
they have proved valueless thus far.

Many of these

measures were devised prior to the recent advancements
in the knowledge of the etiology and are based upon
faulty premises.
The production of a sterile turpentine abscess has
been used (Taussig - 124) and according to some has been
followed by a turn for the be~ter.

The proponents of

this measure point to the peripheral leukoeytoe1s seen
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in a normal per~on after such a procedure.

Turpentine

probably acts as chemotactic substance, either primariJ;r
or secondarily, causing mobilization of~formed leukocytes.

If this be true it will be of little or no value

in granulocytic therapy for in this disease there are
no ~eforrned cells to be mobilized.
nhole milk given intramuscularly has been tried, its
rationale based upon the same premises as the turpentine
abscess and is hence as valueless.

{Dameshek - 23)

Intramuscular injections of epinephrine (Harkins 52) because of the tendency to increase the peripheral
leukocytes in the normal individual were used, but have
been of little value.
Neoarsnhenanine was used quite extensively in the
early history of this disease, (Taussig - 124).

About

10% of the patients showed a blood invasion of Borrelia
v1ncenti.

It was believed that this organism might be

an etiological factor.

Taussig {124) reported thirty-

three cases · treated with a 74% mortality compared with
a control group of 80-90% mortality.

The small number

of patients reduces the significance of the report.
Newer advances in the understanding of the ttlology has
removed this agent from consideration as effective
therapy.
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The use· of sodium thiosulfate has been suggested
in those cases in which arsenic is imn1icated in the
etiology and this may be a valuable adjuvant to other
therapy.
D1nbtheria antitoxin (Hueper - 57) was much used
drug in the early history of this disease because of
confusion in .1 tbe diagnosis.

Polyvalent streptoccus

~erum was given intramusclarly in many of the early

cases.

Intravenous mercuroehrome, gentian violet and

acroflavin and organic iodides have been used.
The possibl1ty of an infective of this disease
cromnted certain investigators to investigate a "immune
serum" (Fisher - 36).

Blood of patients having recovered

from this disease was used in one natient, the patient
~ecovered.
value.

Beck (7) believes that this might have some

He also treated a patient with recovery.

were the only two
by this method.

These

n~t1ents in literature that were treated
This method has l~st its appeal since

the recent advancement of the ·understanding of the etiology
Calcium glucenat was used by Hare (51) in 1932.
Its use was suggested by its a.lledged effectiveness
in the allergic state.

It was at tbis · t1me tbat · the

factor of allergy in the et1o1ogy of grariulocytooen1a
was so ootiular.

The -oatient treated by Hare recovered.
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Squibb's leucocytic extract, an attempt at concen-·
tration of the maturation factor, has been used by many.
Delatour (29) renorted that it has little if any effect
upon the increase in number of leukocytes.

Hamburger

(50) reports he used it with indifferent results.

(76)

Beek

advises giving daily intramuscularly injections of

50 cubic centimeters of Squibb's leukocytic extract, believing it may be of some value.

Harkins (53) used

700 cubic centimeters every four hours for eight days.
Definitely gratifytng results are lacking. ·
The spleen was so freauently enlarged in this condition and 1s so frequently incriminated 1n other blood
dyscrasias that it was again suspected in granuloeytopenia.
Baldridge (5) found no improvement after its removal.
Hueper (57) irrad1cated the spleen in one of his eases
and found 1t to be of little demonstrable value.
One of the most recent investigations of the effect
of various vitamins and related compounds upon the depressive effect of the sulfonamides on leukopoes1s was
that of Axelrod et al. (3).

These men induced a pro-

found 1eukopen1a (with a relative granulopenia) in albino
rats by feeding them purified diets to which one per eent
sulfaguan1dine ha,d been added.
were used in- the experiment.

One hundred thirty rats
Fifty-eight of . these were

given ~o therapy, these promptly developed leukopen1a.
The rema1ntng seventy-two were treated variously wlth
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(1) B1otr1n, (2) Biotin and param1no benzotc acid,
(3) Biotin and Fol ic acid , (4) Fol1c acid alone, (5)
Whole liver.

Biotin was selected because of its stimu-

lating effect on cell multiplication.

The Biotin-Folio

acid therapy proved very effective against the depressive ,
effect of the sulfaguanid1ne, a leukocytos1s was manifest.

Folic acid per ae, though seemingly not as effect-

ive, was quite effective.
ive as Fol.le acid.

Whole liver proved as effect-

The other two com pou~ds failed to

produce any change in the depression.

As long as the

Fol1c acid, whole liver, or Foltc acid and Bioi lffl were
fed the sulfaguanid1ne could be administered with impuntty.

•

Though there are no clinical reports to substantiate
these findings it appears that Folic acid might be effective in controlling the leukopoet1c depression resulting
from sulfonamide administration.
Other interesting, but wholly ineffective, therapeutic mea~ures include blood from a leuhemic patient,
extract of feta.l liver,. high vi ta.min A and C andl1tge
doses of Ferrous sulfate.

'
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Conclusion
The purpose of this paper was to show how granulocytopenia has been established as a clinical entity,
to discuss the etiology, symptomatology, pathology and
prognosis, and to pay especial attention to the therapy.
It was found that though many therapeutic measures have
been advanced, none has been universally effective.

Those

measures proving most effective have been pentose nucleotides, yellow bone marrow, liver extract, and leukocytic
cream. ·There is· no evidence that any of these measures
warrant being called specific.
Prevention then remains the only truly effective
measure.

Those chemicals known to precipitate the

disease should be avoided.
possible·.

This 1s, however, not always

Many invaluable drugs may be implicated.

When it is necessary to use these drugs, they should
be used only with caution.
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